|
Title
|
FOA/Notice Number
|
Related |
Issuing Org
|
Released ▼
|
Opens
|
Expires
|
Activity Code
|
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) |
PA-20-222 |
Related |
NIH
| 05-29-2020 |
05-22-2020 |
05-08-2023 |
(Admin Supp) |
| Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C/TL1 - Clinical Trial Not Allowed) |
PAR-20-220 |
Related |
NIDDK
| 05-28-2020 |
08-28-2020 |
09-29-2022 |
U2C |
| Limited Competition: National Primate Research Centers (P51) Program |
PAR-20-181 |
Related |
ORIP
| 05-27-2020 |
08-25-2020 |
05-26-2023 |
P51 |
| Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required) |
PAR-20-219 |
Related |
NCCIH
(formerly NCCAM)
| 05-20-2020 |
06-20-2020 |
05-08-2023 |
U24 |
| NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required) |
PAR-20-218 |
Related |
NCCIH
(formerly NCCAM)
| 05-20-2020 |
06-20-2020 |
05-08-2023 |
R61/R33 |
| NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) |
PAR-20-217 |
Related |
NCCIH
(formerly NCCAM)
| 05-20-2020 |
06-20-2020 |
05-08-2023 |
R33 |
| NCCIH Natural Product Mid Phase Clinical Trial Cooperative Agreement (U01 Clinical Trial Required) |
PAR-20-216 |
Related |
NCCIH
(formerly NCCAM)
| 05-20-2020 |
06-20-2020 |
05-08-2023 |
U01 |
| Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required) |
PAR-20-215 |
Related |
NCCIH
(formerly NCCAM)
| 05-20-2020 |
06-20-2020 |
05-08-2023 |
UG3/UH3 |
| NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Independent Clinical Trial Not Allowed) |
PAR-20-210 |
Related |
NIAID
| 05-14-2020 |
05-12-2020 |
01-08-2023 |
K99/R00 |
| NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required) |
PAR-20-209 |
Related |
NIAID
| 05-14-2020 |
05-12-2020 |
01-08-2023 |
K99/R00 |
| Eradication of HIV-1 from Central Nervous system Reservoirs (R01 Clinical Trial Not Allowed) |
PA-20-151 |
Related |
NIMH
| 05-13-2020 |
08-07-2020 |
05-08-2023 |
R01 |
| HIV Infection of the Central Nervous System (R01 Clinical Trial Not Allowed) |
PA-20-149 |
Related |
NIMH
| 05-13-2020 |
08-07-2020 |
05-08-2023 |
R01 |
| Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed) |
PA-20-203 |
Related |
NIH
| 05-12-2020 |
05-12-2020 |
05-08-2023 |
K08 |
| Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required) |
PA-20-202 |
Related |
NIH
| 05-12-2020 |
05-12-2020 |
05-08-2023 |
K08 |
| Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Basic Experimental Studies with Humans Required) |
PA-20-201 |
Related |
NIH
| 05-12-2020 |
05-12-2020 |
05-08-2023 |
K08 |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required) |
PA-20-206 |
Related |
NIH
| 05-12-2020 |
05-12-2020 |
05-08-2023 |
K23 |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) |
PA-20-205 |
Related |
NIH
| 05-11-2020 |
05-12-2020 |
05-08-2023 |
K23 |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Basic Experimental Studies with Humans Required) |
PA-20-204 |
Related |
NIH
| 05-11-2020 |
05-12-2020 |
05-08-2023 |
K23 |
| Substance Use/Substance Use Disorder Dissertation Research Award (R36 - Clinical Trials Optional) |
PA-20-208 |
Related |
NIDA
| 05-08-2020 |
05-16-2020 |
05-08-2023 |
R36 |
| NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) |
PA-20-207 |
Related |
NIH
| 05-08-2020 |
07-12-2020 |
05-08-2023 |
R13 |
| Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed) |
PA-20-199 |
Related |
NIH
| 05-07-2020 |
05-12-2020 |
05-08-2023 |
K25 |
| Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Required) |
PA-20-197 |
Related |
NIH
| 05-07-2020 |
05-12-2020 |
05-08-2023 |
K25 |
| Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimental Studies with Humans Required) |
PA-20-198 |
Related |
NIH
| 05-07-2020 |
05-12-2020 |
05-08-2023 |
K25 |
| NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) |
PA-20-200 |
Related |
NIH
| 05-07-2020 |
05-16-2020 |
05-08-2023 |
R03 |
| NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) |
PA-20-195 |
Related |
NIH
| 05-07-2020 |
05-16-2020 |
05-08-2023 |
R21 |
| NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) |
PA-20-194 |
Related |
NIH
| 05-07-2020 |
05-16-2020 |
05-08-2023 |
R21 |
| NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required) |
PA-20-196 |
Related |
NIH
| 05-07-2020 |
05-16-2020 |
05-08-2023 |
R21 |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required) |
PA-20-176 |
Related |
NIH
| 05-07-2020 |
05-12-2020 |
05-08-2023 |
K01 |
| Mentored Research Scientist Development Award (Parent K01 Independent Basic Experimental Studies with Humans Required) |
PA-20-191 |
Related |
NIH
| 05-07-2020 |
05-12-2020 |
05-08-2023 |
K01 |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) |
PA-20-190 |
Related |
NIH
| 05-07-2020 |
05-12-2020 |
05-08-2023 |
K01 |
| Midcareer Investigator Award in Patient-Oriented Research (Parent K24 - Independent Basic Experimental Studies with Humans Required) |
PA-20-192 |
Related |
NIH
| 05-06-2020 |
05-12-2020 |
05-08-2023 |
K24 |
| Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required) |
PA-20-193 |
Related |
NIH
| 05-06-2020 |
05-12-2020 |
05-08-2023 |
K24 |
| Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Not Allowed) |
PA-20-186 |
Related |
NIH
| 05-06-2020 |
05-12-2020 |
05-08-2023 |
K24 |
| NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required) |
PA-20-187 |
Related |
NIH
| 05-05-2020 |
05-12-2020 |
05-08-2023 |
K99/R00 |
| NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed) |
PA-20-188 |
Related |
NIH
| 05-05-2020 |
05-12-2020 |
05-08-2023 |
K99/R00 |
| NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies with Humans Required) |
PA-20-189 |
Related |
NIH
| 05-05-2020 |
05-12-2020 |
05-08-2023 |
K99/R00 |
| NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) |
PA-20-185 |
Related |
NIH
| 05-05-2020 |
05-05-2020 |
05-08-2023 |
R01 |
| Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required) |
PA-20-184 |
Related |
NIH
| 05-05-2020 |
05-05-2020 |
05-08-2023 |
R01 |
| Research Project Grant (Parent R01 Clinical Trial Required) |
PA-20-183 |
Related |
NIH
| 05-05-2020 |
05-05-2020 |
05-08-2023 |
R01 |
| Large scale mapping and/or molecular profiling of ensembles and/or cell-types mediating opioid action in the rodent brain (R01 - Clinical Trial Not Allowed) |
PAR-20-182 |
Related |
NIDA
| 05-04-2020 |
09-30-2020 |
10-31-2020 |
R01 |
| Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity (R01 Clinical Trial Optional) |
PAR-20-179 |
Related |
ODP
| 04-30-2020 |
09-05-2020 |
09-08-2023 |
R01 |
| Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional) |
PAR-20-180 |
Related |
ODP
| 04-30-2020 |
09-05-2020 |
09-08-2023 |
R01 |
| Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed) |
PAR-20-177 |
Related |
NIAID
| 04-30-2020 |
04-30-2020 |
04-30-2021 |
R21 |
| Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed) |
PAR-20-178 |
Related |
NIAID
| 04-30-2020 |
04-30-2020 |
04-30-2021 |
R01 |
| Competitive Revision Supplements to Existing AHRQ Patient Centered Outcomes Research (PCOR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional) |
PA-20-072 |
Related |
AHRQ
| 04-29-2020 |
04-29-2020 |
06-01-2020 |
(Admin Supp) |
| Competitive Revision Supplements to Existing AHRQ Health Service Research (HSR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional) |
PA-20-070 |
Related |
AHRQ
| 04-29-2020 |
04-29-2020 |
06-01-2020 |
(Admin Supp) |
| IDeA Program Infrastructure for Clinical and Translational Research (IDeA-CTR)(U54 - Clinical Trial Optional) |
PAR-20-175 |
Related |
NIGMS
| 04-24-2020 |
09-07-2020 |
10-08-2022 |
U54 |
| Independent Scientist Award (Parent K02 - Independent Clinical Trial Not Allowed) |
PA-20-174 |
Related |
NIH
| 04-23-2020 |
05-12-2020 |
05-08-2023 |
K02 |
| Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans Required) |
PA-20-173 |
Related |
NIH
| 04-23-2020 |
05-12-2020 |
05-08-2023 |
K02 |
| Independent Scientist Award (Parent K02 - Independent Clinical Trial Required) |
PA-20-171 |
Related |
NIH
| 04-23-2020 |
05-12-2020 |
05-08-2023 |
K02 |
| Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) |
PA-20-172 |
Related |
NIMHD
| 04-20-2020 |
09-04-2020 |
09-08-2023 |
R01 |
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) |
PA-20-166 |
Related |
NIH
| 04-20-2020 |
04-21-2020 |
05-22-2023 |
(Admin Supp) |
| Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional) |
PAR-20-167 |
Related |
NIH
| 04-15-2020 |
07-28-2020 |
08-29-2020 |
SI2/R00 |
| New Informatics Tools and Methods to Enhance U.S. Cancer Surveillance Research (U01 Clinical Trial Optional) |
PAR-20-170 |
Related |
NCI
| 04-15-2020 |
10-18-2020 |
06-07-2023 |
U01 |
| National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional) |
PAR-20-169 |
Related |
NIBIB
| 04-14-2020 |
04-25-2020 |
05-08-2023 |
P41 |
| Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R01 Clinical Trials Not Allowed) |
PAR-20-165 |
Related |
NINDS
| 04-13-2020 |
05-05-2020 |
03-06-2023 |
R01 |
| Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R21 Clinical Trials Not Allowed) |
PAR-20-168 |
Related |
NINDS
| 04-13-2020 |
05-16-2020 |
05-08-2023 |
R21 |
| Competing Revisions to Existing NIH Grants and Cooperative Agreements (Clinical Trial Optional) |
PA-20-163 |
Related |
NIH
| 04-03-2020 |
03-17-2020 |
03-17-2023 |
332 |
| Mechanisms and Consequences of Sleep Disparities in the U.S. (R01 - Clinical Trial Not Allowed) |
PAR-20-164 |
Related |
NIMHD
| 04-03-2020 |
06-12-2020 |
07-15-2022 |
R01 |
| Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35) |
PA-20-162 |
Related |
NIH
| 04-02-2020 |
04-25-2020 |
05-08-2023 |
T35 |
| Catalyzing Innovation in Pediatric Pharmacology Clinical Trial Design and Resource Access (X01 Clinical Trial Not Allowed) |
PAR-20-161 |
Related |
NICHD
| 04-02-2020 |
08-14-2020 |
03-18-2023 |
X01 |
| Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional) |
PAR-20-157 |
Related |
NIMH
| 03-31-2020 |
05-05-2020 |
05-08-2023 |
R01 |
| Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional) |
PAR-20-159 |
Related |
NIMH
| 03-31-2020 |
05-16-2020 |
05-08-2023 |
R21 |
| Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required) |
PAS-20-160 |
Related |
NIDDK
| 03-31-2020 |
05-05-2020 |
05-08-2023 |
R01 |
| Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed) |
PAR-20-158 |
Related |
NIAID
| 03-31-2020 |
06-29-2020 |
07-29-2022 |
R01 |
| Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01 Clinical Trial Optional) |
PAR-20-156 |
Related |
NIA
| 03-31-2020 |
05-05-2020 |
05-08-2023 |
R01 |
| Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) |
PAR-20-155 |
Related |
NCI
| 03-30-2020 |
05-05-2020 |
09-08-2022 |
R01 |
| Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required) |
PAR-20-154 |
Related |
NCCIH
(formerly NCCAM)
| 03-30-2020 |
05-05-2020 |
05-08-2023 |
R01 |
| NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed) |
PAR-20-153 |
Related |
NIGMS
| 03-30-2020 |
06-14-2020 |
07-14-2022 |
R25 |
| NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional) |
PAR-20-150 |
Related |
NIMHD
| 03-26-2020 |
05-16-2020 |
05-08-2023 |
R21 |
| Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection (R21- Clinical Trial Not Allowed) |
PAR-20-148 |
Related |
NIDA
| 03-25-2020 |
09-13-2020 |
05-08-2023 |
R21 |
| Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection (R01- Clinical Trial Not Allowed) |
PAR-20-147 |
Related |
NIDA
| 03-25-2020 |
09-13-2020 |
05-08-2023 |
R01 |
| NIDA Small Research Grant Program (R03 Clinical Trial Required) |
PA-20-146 |
Related |
NIDA
| 03-24-2020 |
05-16-2020 |
05-08-2023 |
R03 |
| Innovations in HIV Prevention, Testing, Adherence and Retention to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional) |
PA-20-145 |
Related |
NIMH
| 03-23-2020 |
04-07-2020 |
01-08-2023 |
R21 |
| Innovations in HIV Prevention, Testing, Adherence and Retention to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional) |
PA-20-144 |
Related |
NIMH
| 03-23-2020 |
04-07-2020 |
01-08-2023 |
R01 |
| Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) |
PA-20-142 |
Related |
NIH
| 03-20-2020 |
04-25-2020 |
05-26-2023 |
T32 |
| Formative and Pilot Intervention Research for Prevention and Treatment of HIV/AIDS (R34 Clinical Trial Optional) |
PA-20-141 |
Related |
NIMH
| 03-19-2020 |
04-07-2020 |
01-08-2023 |
R34 |
| Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed) |
PAR-20-140 |
Related |
NIDDK
| 03-16-2020 |
05-16-2020 |
05-08-2023 |
R21 |
| Center of Excellence for Research on Complementary and Integrative Health (P01,Clinical Trial Optional) |
PAR-20-138 |
Related |
NCCIH
(formerly NCCAM)
| 03-16-2020 |
04-25-2020 |
05-08-2023 |
P01 |
| Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) |
PAR-20-139 |
Related |
NIAID
| 03-13-2020 |
04-13-2020 |
01-14-2023 |
R01 |
| Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) |
PAR-20-131 |
Related |
NCI
| 03-12-2020 |
05-05-2020 |
05-08-2023 |
R01 |
| In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed) |
PAR-20-137 |
Related |
NICHD
| 03-12-2020 |
05-05-2020 |
11-06-2022 |
R01 |
| Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed) |
PAR-20-136 |
Related |
NCI
| 03-12-2020 |
03-07-2020 |
11-10-2022 |
U01 |
| Development of Wearable Smart Devices for Continuous Monitoring of Circulating Nutrients, Metabolites and Hormones (R21/R33 Clinical Trial Required) |
PAR-20-134 |
Related |
NIDDK
| 03-11-2020 |
05-18-2020 |
06-09-2021 |
R21/R33 |
| Gastrointestinal (GI) and Microbiome Explorers: Development of Swallowable Smart Pills or Devices for Precision Nutrition, Microbiome and Digestive Disease Applications (R21/R33 Clinical Trial Required) |
PAR-20-133 |
Related |
NIDDK
| 03-11-2020 |
05-18-2020 |
06-09-2021 |
R21/R33 |
| Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) |
PA-20-135 |
Related |
NIH
| 03-10-2020 |
03-03-2020 |
09-08-2025 |
(Admin Supp) |
| Research Towards Developing a Cure for HBV in HIV/HBV Co-Infection (R21 Clinical Trial Not Allowed) |
PAS-20-121 |
Related |
NIAID
| 03-06-2020 |
04-07-2020 |
01-08-2022 |
R21 |
| NICHD Biomedical Informatic Resource Centers Grants (P41 Clinical Trial Not Allowed) |
PAR-20-126 |
Related |
NICHD
| 03-05-2020 |
04-25-2020 |
05-08-2023 |
P41 |
| Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional) |
PAR-20-125 |
Related |
NIGMS
| 03-05-2020 |
05-24-2020 |
07-24-2021 |
S06 |
| Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional) |
PAR-20-123 |
Related |
NIDCD
| 03-05-2020 |
04-07-2020 |
01-08-2023 |
R21 |
| Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional) |
PAR-20-127 |
Related |
NIDCD
| 03-05-2020 |
04-07-2020 |
01-08-2023 |
R01 |
| NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens (U01) Clinical Trials Not Allowed |
PAR-20-124 |
Related |
FDA
| 03-05-2020 |
03-09-2020 |
05-03-2022 |
U01 |
| Integrated Preclinical / Clinical AIDS Vaccine Development Program (IPCAVD)
(U19 Clinical Trial Not Allowed) |
PAR-20-120 |
Related |
NIAID
| 03-03-2020 |
06-28-2020 |
03-10-2022 |
U19 |
| Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) |
PAR-20-111 |
Related |
NINDS
| 03-03-2020 |
07-11-2020 |
05-08-2023 |
U44 |
| Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) |
PAR-20-122 |
Related |
NINDS
| 03-03-2020 |
07-11-2020 |
05-08-2023 |
UG3/UH3 |
| National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Disorder (U19 Clinical Trial Optional) |
PAR-20-119 |
Related |
NIMH
| 02-25-2020 |
02-25-2020 |
03-26-2022 |
U19 |
| National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Disorder (U01 Clinical Trial Optional) |
PAR-20-118 |
Related |
NIMH
| 02-25-2020 |
06-27-2020 |
03-26-2022 |
U01 |
| Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (R35 - Clinical Trial Optional) |
PAR-20-117 |
Related |
NIGMS
| 02-24-2020 |
09-02-2020 |
10-04-2022 |
R35 |
| Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed) |
PAR-20-116 |
Related |
NCI
| 02-24-2020 |
04-21-2020 |
11-19-2021 |
R01 |
| Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30 Clinical Trial Optional) |
PAR-20-115 |
Related |
NIGMS
| 02-20-2020 |
04-28-2020 |
05-28-2022 |
P30 |
NIH Staff 
